Synthetic Blood International (SYBD.OB) Changes Name to Oxygen Biotherapeutics, Inc. (OXBO.OB)
As previously announced in June, Synthetic Blood International has changed its name to Oxygen Biotherapeutics, Inc. effective today. The company will continue to trade on the Over-the-Counter Bulletin Board but with a new symbol. Starting with the opening of trading today, the company’s new trading symbol will be OXBO. The company’s focus will continue to be the same. Oxygen Biotherapeutics is dedicated to transforming patient care by developing advanced, oxygen-based therapies using Oxycyte®, the company’s perfluorocarbon (PFC) therapeutic oxygen carrier, and other solutions. The company believes Oxycyte has the potential for use in multiple indications, including traumatic brain injury, sickle-cell…